Trends in Prescription of Stimulants and Narcoleptic Drugs in Switzerland: Longitudinal Health Insurance Claims Analysis for the Years 2014-2021
The prescription of stimulant medication in Switzerland increased slightly but continuously over years, but at lower rates compared to the estimated prevalence of central hypersomnolence disorders and attention-deficit/hyperactivity disorders/attention deficit disorders. Most stimulants are prescribed by psychiatrists, closely followed by general practitioners. The increased odds for hospitalization to psychiatric institutions for stimulant receivers reflects the severity of disease and the higher psychiatric comorbidities in these patients.
Authors
- Zhongxing Zhang (ORCID: https://orcid.org/0000-0003-0184-8882)
- Ramin Khatami (ORCID: https://orcid.org/0000-0002-1092-6160)
- Markus Näpflin
- Tamara Scharf (ORCID: https://orcid.org/0000-0002-4958-4356)
- Carola A. Huber (ORCID: https://orcid.org/0000-0002-2469-0435)
Institutions
- University of Bern (CH)
- University of Zurich (CH)
- University Hospital of Bern (CH)
- University Hospital of Zurich (CH)
- Klinik Barmelweid (CH)
- Helsana Group (Switzerland) (CH)
Publication Details
- Journal
- JMIR Public Health and Surveillance
- Published
- 2024-09-30
- DOI
- https://doi.org/10.2196/53957
- Citations
- 1
- Primary Topic
- Attention Deficit Hyperactivity Disorder
- Type
- article
- Field-Weighted Citation Impact
- 0.39